Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 27, Numéro 3, Mai 2018
Infectieux
Page(s) 279 - 286
Section Comptes-rendus de congrès / Congresses, conferences
DOI https://doi.org/10.3166/rea-2018-0033
Publié en ligne 6 juin 2018
  • Morand PC, Maissa N, Bernard SC, Bourdoulous S, (2014) CD147 is an essential receptor for vascular colonization by Neisseria meningitidis. Med Sci (Paris) 30: 825–827 [CrossRef] [PubMed] [Google Scholar]
  • Bernard SC, Simpson N, Join-Lambert O, Federici C, Laran-Chich MP, Maissa N, Bouzinba-Segard H, Morand PC, Chretien F, Taouji S, Chevet E, Janel S, Lafont F, Coureuil M, Segura A, Niedergang F, Marullo S, Couraud PO, Nassif X, Bourdoulous S, (2014) Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization. Nat Med 20: 725–731 [CrossRef] [PubMed] [Google Scholar]
  • Coureuil M, Lecuyer H, Scott MG, Boularan C, Enslen H, Soyer M, Mikaty G, Bourdoulous S, Nassif X, Marullo S, (2010) Meningococcus hijacks a beta2-adrenoceptor/beta-arrestin pathway to cross brain microvasculature endothelium. Cell 143: 1149–1160 [CrossRef] [PubMed] [Google Scholar]
  • Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, Nunez G, (2012) Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336: 1325–1329 [Google Scholar]
  • Sansonetti PJ, Tran Van Nhieu G, Egile C, (1999) Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri. Clin Infect Dis 28: 466–475 [CrossRef] [PubMed] [Google Scholar]
  • Kasper CA, Sorg I, Schmutz C, Tschon T, Wischnewski H, Kim ML, Arrieumerlou C, (2010) Cell-cell propagation of NF-kappaB transcription factor and MAP kinase activation amplifies innate immunity against bacterial infection. Immunity 33: 804–816 [CrossRef] [PubMed] [Google Scholar]
  • Bergounioux J, Elisee R, Prunier AL, Donnadieu F, Sperandio B, Sansonetti P, Arbibe L, (2012) Calpain activation by the Shigella flexneri effector VirA regulates key steps in the formation and life of the bacterium’s epithelial niche. Cell Host Microbe 11: 240–252 [CrossRef] [PubMed] [Google Scholar]
  • Arbibe L, Kim DW, Batsche E, Pedron T, Mateescu B, Muchardt C, Parsot C, Sansonetti PJ, (2007) An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 8: 47–56 [CrossRef] [PubMed] [Google Scholar]
  • Hotchkiss RS, Moldawer LL, (2014) Parallels between cancer and infectious disease. N Engl J Med 371: 380–383 [CrossRef] [PubMed] [Google Scholar]
  • Cavassani KA, Carson WFt, Moreira AP, Wen H, Schaller MA, Ishii M, Lindell DM, Dou Y, Lukacs NW, Keshamouni VG, Hogaboam CM, Kunkel SL, (2010) The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood 115: 4403–4411 [Google Scholar]
  • Llitjos JF, Auffray C, Alby-Laurent F, Rousseau C, Merdji H, Bonilla N, Toubiana J, Belaidouni N, Mira JP, Lucas B, Chiche JD, Pène F, (2016) Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through toll-like receptor 4. J Pathol 239: 473–483 [CrossRef] [PubMed] [Google Scholar]
  • Buzas K, Marton A, Vizler C, Gyukity-Sebestyen E, Harmati M, Nagy K, Zvara A, Katona RL, Tubak V, Endresz V, Nemeth IB, Olah J, Vigh L, Biro T, Kemeny L, (2016) Bacterial sepsis increases survival in metastatic melanoma: Chlamydophila pneumoniae induces macrophage polarization and tumor regression. J Invest Dermatol 136: 862–865 [CrossRef] [PubMed] [Google Scholar]
  • Chen L, He Z, Qin L, Li Q, Shi X, Zhao S, Chen L, Zhong N, Chen X, (2011) Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity. PLoS One 6: e24407 [CrossRef] [PubMed] [Google Scholar]
  • Drancourt M, Bollet C, Carlioz A, Martelin R, Gayral JP, Raoult D, (2000) 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J Clin Microbiol 38: 3623–3630 [PubMed] [Google Scholar]
  • Raoult D, Birg ML, La Scola B, Fournier PE, Enea M, Lepidi H, Roux V, Piette JC, Vandenesch F, Vital-Durand D, Marrie TJ, (2000) Cultivation of the bacillus of Whipple’s disease. N Engl J Med 342: 620–625 [CrossRef] [PubMed] [Google Scholar]
  • Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D, (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49: 543–551 [Google Scholar]
  • Lagier JC, Armougom F, Million M, Hugon P, Pagnier I, Robert C, Bittar F, Fournous G, Gimenez G, Maraninchi M, Trape JF, Koonin EV, La Scola B, Raoult D, (2012) Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect 18: 1185–1193 [CrossRef] [PubMed] [Google Scholar]
  • Byrd AL, Segre JA, (2016) Infectious disease. Adapting Koch’s postulates. Science 351: 224–226 [Google Scholar]
  • Lagier JC, Raoult D, (2016) Fecal microbiota transplantation: indications and perspectives. Med Sci (Paris) 32: 991–997 [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  • Angelakis E, Merhej V, Raoult D, (2013) Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis 13: 889–899 [CrossRef] [PubMed] [Google Scholar]
  • Li J, Sung CY, Lee N, Ni Y, Pihlajamaki J, Panagiotou G, El-Nezami H, (2016) Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci U S A 113: E1306–E1315 [CrossRef] [PubMed] [Google Scholar]
  • Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillere R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragon L, Jacquelot N, Qu B, Ferrere G, Clemenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L, (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359: 91–97 [Google Scholar]
  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC, (2016) The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA 315: 801–810 [CrossRef] [PubMed] [Google Scholar]
  • Vincent JL, Teixeira L, (2014) Sepsis biomarkers. Value and limitations. Am J Respir Crit Care Med 190: 1081–1082 [CrossRef] [PubMed] [Google Scholar]
  • Fenollar F, Raoult D, (2007) Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 30: S7–S15 [CrossRef] [PubMed] [Google Scholar]
  • Kaleta EJ, Clark AE, Johnson DR, Gamage DC, Wysocki VH, Cherkaoui A, Schrenzel J, Wolk DM, (2011) Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. J Clin Microbiol 49: 345–353 [CrossRef] [PubMed] [Google Scholar]
  • Bacconi A, Richmond GS, Baroldi MA, Laffler TG, Blyn LB, Carolan HE, Frinder MR, Toleno DM, Metzgar D, Gutierrez JR, Massire C, Rounds M, Kennel NJ, Rothman RE, Peterson S, Carroll KC, Wakefield T, Ecker DJ, Sampath R, (2014) Improved sensitivity for molecular detection of bacterial and Candida infections in blood. J Clin Microbiol 52: 3164–3174 [CrossRef] [PubMed] [Google Scholar]
  • Vincent JL, Brealey D, Libert N, Abidi NE, O’Dwyer M, Zacharowski K, Mikaszewska-Sokolewicz M, Schrenzel J, Simon F, Wilks M, Picard-Maureau M, Chalfin DB, Ecker DJ, Sampath R, Singer M, (2015) Rapid diagnosis of infection in the critically ill, a multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections. Crit Care Med 43: 2283–2291 [CrossRef] [PubMed] [Google Scholar]
  • Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grunewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J, (2016) Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med 374: 636–646 [CrossRef] [PubMed] [Google Scholar]
  • Davey RT Jr, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy D, (2016) A randomized, controlled trial of ZMapp for Ebola virus infection. N Engl J Med 375: 1448–1456 [CrossRef] [PubMed] [Google Scholar]
  • Dufour N, Debarbieux L, Fromentin M, Ricard JD, (2015) Treatment of highly virulent extra-intestinal pathogenic Escherichia coli pneumonia with bacteriophages. Crit Care Med 43: e190–198 [CrossRef] [PubMed] [Google Scholar]
  • Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T, (2017) Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother 61: e00954–17 [CrossRef] [PubMed] [Google Scholar]
  • Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB, (2012) Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy. Clin Infect Dis 55: 1188–1197 [CrossRef] [PubMed] [Google Scholar]
  • Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, Lu X, O’Malley J, Kinzel K, Zaidi T, Rey A, Perrin C, Fichorova RN, Kayatani AK, Maira-Litran T, Gening ML, Tsvetkov YE, Nifantiev NE, Bakaletz LO, Pelton SI, Golenbock DT, Pier GB, (2013) Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A 110: E2209–E2218 [CrossRef] [PubMed] [Google Scholar]
  • Skurnik D, Cywes-Bentley C, Pier GB, (2016) The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG. Expert Rev Vaccines 15: 1041–1053 [CrossRef] [PubMed] [Google Scholar]
  • Skurnik D, Roux D, Pons S, Guillard T, Lu X, Cywes-Bentley C, Pier GB, (2016) Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 71: 927–935 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.